Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biovail Added to S&P / Toronto Stock Exchange - TSE - 60 Index, Listing to Commence November 2, 2000.


Business Editors, Health/Medical Writers

TORONTO--(BW HealthWire)--Nov. 1, 2000

Biovail Corporation (NYSE NYSE

See: New York Stock Exchange
:BVF) (TSE See Tokyo Stock Exchange.

TSE

1. See Tokyo Stock Exchange (TSE).

2. See Toronto Stock Exchange (TSE).
:BVF) announced today that it has received notification that the Company will be added to the healthcare sector of the Standard & Poors / Toronto Stock Exchange Toronto Stock Exchange (TSE)

Canada's largest stock exchange, trading approximately 1,200 company stocks and 33 options.
 60 Index, effective Thursday, November 2, 2000.

Biovail Corporation is an international full-service pharmaceutical company, engaged in the formulation, clinical testing, registration, manufacture, sale and promotion of drug products utilizing advanced drug delivery technologies.

"Safe Harbor" statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995.

To the extent any statements made in this release contain information that is not historical, these statements are essentially forward looking and are subject to risks and uncertainties, including the difficulty of predicting FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Nov 1, 2000
Words:175
Previous Article:CMHC Systems to Exhibit Latest Generation Products at Tennessee Association of Mental Health Organizations Conference.
Next Article:Rutherford Institute Attacks Penthouse and Paula Jones Over Her Nude Pictorial in the December Issue.
Topics:



Related Articles
TIPS diversifies an equity investment with limited funds.
Biovail announces 3-for-1 stock split.
Biovail and Fuisz Announce Results of Tender Offer.
Biovail / Fuisz Merger Approved.
Biovail Included in Toronto Stock Exchange - TSE - 100 Index; Listing to Commence November 17, 1998.
Biovail Announces Proposed Stock Split and the Expiration of Biovail Technologies Ltd.'s Offer to Purchase Its Outstanding 7% Convertible...
The Investment Reporter beats the Toronto Stock Exchange 300 composite.
FDA APPROVES BIOVAIL'S GENERIC PROCARDIA XL 30MG DOSAGE.
Biovail Comments On Florida Court Hearing.
Biovail Included in Toronto Stock Exchange --TSE-- 35 Index; Listing to Commence May 11, 2001.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles